DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Biomarkers Enabling Diabetes and Obesity Management" report to their offering.
Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management of obesity, diabetes and related complications in the near future.
There are several biomarkers that are currently being studied for predicting the risk and progression of several diseases such as type 2 diabetes, diabetic kidney disease, obesity and related disorders. Furthermore, companies are looking to leverage new biomarker-based platforms for early diagnosis and timely clinical management of obesity, diabetes and related complications. Biomarker-based research may also open novel paradigms for drug discovery and development obesity and diabetes disorders.
Key Topics Covered:
1. Executive Summary
2. Role of Biomarkers in Diabetes and Obesity Management
3. Impact Analysis and Assessment
4. Basic Research Applications
5. Diagnostic Applications
6. Drug Discovery and Development Applications
7. Strategic Insights and Future Perspectives
8. Overview of the Patent Landscape
9. Growth Opportunities and Companies to Action
For more information about this report visit http://www.researchandmarkets.com/research/q6nlsd/biomarkers